PROF

Profound Medical Corp. is a pioneering Canadian medical technology firm based in Mississauga, specializing in innovative therapeutic solutions for prostate cancer. The company's flagship product, the TULSA-PRO system, combines real-time MRI imaging with ultrasound technology, allowing for precise targeting of prostate tissue while minimizing damage to surrounding healthy structures. Committed to advancing patient care through minimally invasive techniques, Profound Medical is positioned at the forefront of urology innovation and is actively pursuing global expansion through strategic research initiatives and collaborations. As the company continues to enhance the standard of care, it remains dedicated to improving patient outcomes and solidifying its leadership within the healthcare industry.